# Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial

> **NCT03228030** · PHASE1 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 24 (actual)

## Conditions studied

- Heart Failure
- Heart Failure With Reduced Ejection Fraction
- Thiamine Deficiency
- Congestive Heart Failure

## Interventions

- **DIETARY_SUPPLEMENT:** Thiamine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03228030
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-02
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03228030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03228030, "Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03228030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*